BTAI icon

BioXcel Therapeutics

104 hedge funds and large institutions have $388M invested in BioXcel Therapeutics in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 17 closing their positions.

Holders
104
Holders Change
-5
Holders Change %
-4.59%
% of All Funds
1.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
50
Reduced
26
Closed
17
Calls
$6.54M
Puts
$6.84M
Net Calls
-$301K
Net Calls Change
+$2.7M
Name Market Value Shares Shares
Change
Shares
Change %
AIM
101
Anchor Investment Management
South Carolina
$1.03K 34 +34 New
BCA
102
Berman Capital Advisors
Georgia
$1K 33 +33 New
S
103
SignatureFD
Georgia
$1K 40 +40 New
CCM
104
CAAS Capital Management
New York
-232,285 Closed
LM
105
Luminus Management
Texas
-157,099 Closed
Blackstone Inc
106
Blackstone Inc
New York
-150,000 Closed
LCM
107
Laurion Capital Management
New York
-100,000 Closed
MIM
108
Monashee Investment Management
Massachusetts
-60,000 Closed
HF
109
HRT Financial
New York
-53,138 Closed
KCM
110
Kennedy Capital Management
Missouri
-40,532 Closed
GH
111
GAM Holding
Switzerland
-15,600 Closed
HAG
112
HighPoint Advisor Group
Illinois
-12,185 Closed
TC
113
TwinBeech Capital
New York
-8,750 Closed
EGM
114
Engineers Gate Manager
New York
-7,650 Closed
BFM
115
Boothbay Fund Management
New York
-7,186 Closed
Russell Investments Group
116
Russell Investments Group
United Kingdom
-647 Closed
ASN
117
Advisory Services Network
Georgia
-315 Closed
GAM
118
Gemmer Asset Management
California
-100 Closed
TWA
119
TCI Wealth Advisors
Arizona
-61 Closed
Northwestern Mutual Wealth Management
120
Northwestern Mutual Wealth Management
Wisconsin
-30 Closed
HI
121
Harbour Investments
Wisconsin
$0 3 -1 -25%
CFGS
122
Concourse Financial Group Securities
Alabama
IA
123
IFP Advisors
Florida